SwisscheM Healthcare - Top Pharma Franchise Company in India

What SwisscheM Healthcare - Top Pharma Franchise Company in India does

SwisscheM Healthcare is a privately held Indian pharmaceutical company headquartered in Panchkula, Haryana, that self-positions as a "Top Pharma Franchise Company in India." Based on the firmographic profile — founded 2015, approximately 10 employees, single India location, no disclosed subsidiaries, no funding rounds, and no public ticker — the entity appears to operate as a micro/small-scale pharma franchise (PCD — Propaganda-Cum-Distribution) operator, a common Indian business model in which a firm markets and distributes pharma products through third-party franchisees and stockists rather than through its own retail or hospital channels.

No products, therapeutic categories, dosage forms, APIs, or manufacturing capabilities were disclosed in the source data. The core technology, proprietary features, and value-proposition fields are all empty, and the company's website (swisschem.in) returned only a loader/verification page with no extractable content, so product portfolio, manufacturing partnerships (own plant vs. loan-license vs. third-party), certifications (GMP/ISO/WHO-GMP/DCGI approvals), and product list cannot be confirmed. Revenue mechanics are similarly undisclosed: no pricing models, no publicly disclosed pricing, no marketing channels, no distribution channel details, and no customer logos or segment breakdown are available.

Ownership structure, management team, investors, awards, patents, partnerships, regulatory actions, and M&A history are all absent from the source. Operating geographies beyond India are not disclosed. In aggregate, the available evidence supports only a minimal descriptive statement: a small, privately held, India-domestic pharma franchise/PCD operator founded in 2015 with ~10 employees and no verifiable commercial footprint in the source data.

Name

SwisscheM Healthcare - Top Pharma Franchise Company in India

Website

https://swisschem.in

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

SwisscheM Healthcare is a small privately held Indian pharmaceutical franchise (PCD) operator, founded in 2015 and headquartered in Panchkula, Haryana, with about 10 employees. The company self-positions as a pan-India pharma franchise distributor, though no products, customers, or revenue details were disclosed.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution & PCD Franchise

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

Keywords

• Pharmaceutical franchise
• Pharma distribution
• Medicines marketing
• Pharma PCD franchise
• Generic medicines

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Core offering

SwisscheM Healthcare is an Indian pharmaceutical franchise company that offers pharma franchise and PCD (Propaganda Cum Distribution) business opportunities for pharmaceutical products. The company distributes a range of medicines and pharma formulations through franchise partners across India. Based in Panchkula, Haryana, the firm provides marketing and distribution rights for its pharma product portfolio to prospective franchisees and distributors.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Broad incumbents

• Cipla: Top-5 Indian pharma major with significant generic formulation presence and franchise/retail distribution. Comparable on therapeutic areas (respiratory, cardiac, anti-infectives) though broader in scope including APIs and biosimilars.
• Alkem Laboratories: Large Indian generic pharma major with extensive franchise/distribution operations across India. Comparable on product portfolio (generics, chronic, acute) and franchise channel, though materially larger and listed.
• Mankind Pharma: India's largest pharma franchise company by volume, dominating the chronic and acute generic franchise segment. Sets the competitive benchmark for franchise economics, doctor coverage, and PCD network scale.
• Torrent Pharmaceuticals: Large Indian generic pharma player with nationwide distribution including franchise channels. Comparable therapeutic mix (cardio, CNS, gastro) though materially larger and listed.

Others

• Akums Drugs & Pharmaceuticals: India's largest contract pharma manufacturer supplying formulations to franchise and marketing companies. Relevant as an upstream supplier/manufacturing partner that a small franchise player like SwisscheM could leverage for product sourcing without owning manufacturing.

Direct peers

• Aristo Pharmaceuticals: Indian generic pharma manufacturer with a nationwide PCD/franchise distribution model. Closely matches SwisscheM's franchise-driven GTM and therapeutic mix.
• Macleods Pharmaceuticals: India-based generic pharma manufacturer that operates one of the country's largest pharma franchise/PCD networks. Directly comparable franchise distribution model targeting Tier-2/3 chemist outlets, with a similar generic formulation focus.
• Franco-Indian Pharmaceuticals: Indian generic pharma manufacturer with PCD/franchise model across therapeutic segments. Direct competitor to SwisscheM for franchisee partners in northern India.
• Blue Cross Laboratories: Mid-sized Indian pharma company with strong franchise/PCD distribution in chronic and acute generics. Comparable scale and franchise-led GTM.

Emerging players

• Alniche Lifesciences: Indian pharma company focused on niche specialty segments (critical care, nephrology) with a PCD/franchise model. Comparable franchise GTM targeting specialty prescribers rather than mass-market chemists.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/swisschem-healthcare

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SwisscheM Healthcare - Top Pharma Franchise Company in India